• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

ZL0420

CAS No. 2229039-45-4

ZL0420 ( ZL-0420;ZL 0420 )

产品货号. M13567 CAS No. 2229039-45-4

ZL0420 is a potent, highly selective BRD4 inhibitor with IC50 of 27 and 32 nM for BRD4-BD1 and BRD4-BD2, respectively.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥786 有现货
10MG ¥1393 有现货
25MG ¥2811 有现货
50MG ¥4836 有现货
100MG ¥6877 有现货
200MG ¥9153 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    ZL0420
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    ZL0420 is a potent, highly selective BRD4 inhibitor with IC50 of 27 and 32 nM for BRD4-BD1 and BRD4-BD2, respectively.
  • 产品描述
    ZL0420 is a potent, highly selective BRD4 inhibitor with IC50 of 27 and 32 nM for BRD4-BD1 and BRD4-BD2, respectively; displays selectivity over BRD2, BRD3, and BRDT (BRD2-BD1 and BRD2-BD2, IC50=803 and 1736 nM); disrupts the BRD4 complex with Pol II and histones, inhibits poly(I:C)-induced expression of innate immune genes IL6 and CIG5 in human small airway epithelial cells (hSAECs) (IC50=0.54 and 0.51 uM); blocks Poly(I:C)-induced inflammation and neutrophilia in vivo.
  • 同义词
    ZL-0420;ZL 0420
  • 通路
    Chromatin/Epigenetic
  • 靶点
    Bromodomain
  • 受体
    Bromodomain
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    2229039-45-4
  • 分子量
    296.33
  • 分子式
    C16H16N4O2
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    CC1=C(O)C=C(N)C(/N=N/C2=CC(CCC(N3)=O)=C3C=C2)=C1
  • 化学全称
    (E)-6-((2-amino-4-hydroxy-5-methylphenyl)diazenyl)-3,4-dihydroquinolin-2(1H)-one

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Tian B, et al. Cell Rep. 2018 Apr 24;23(4):1138-1151.
2. Liu Z, et al. Eur J Med Chem 2018 May 10;151:450-461.
产品手册
关联产品
  • SJ830599

    SJ830599 is a modest selective BRD2-BD2 inhibitor with IC50 of 0.61 uM, 3.3-fold selectivity over BRD2-BD1.

  • Dual BET-Kinase inhi...

    A potent, dual BET bromodomain-kinase inhibitor with IC50 of 34, 1.1 and 1.1 nM for BRD4 BD1, JAK2 and FLT-3, respectively.

  • FT-001

    FT-001 is a novel potent, orally acitve inhibitor of BET bromodomain with IC50 of 0.1 uM for BRD4 BD1.